These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 16351648)
21. Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement. Frank I; Cheville JC; Blute ML; Lohse CM; Karnes RJ; Weaver AL; Sebo TJ; Nehra A; Zincke H Cancer; 2004 Oct; 101(8):1803-8. PubMed ID: 15386300 [TBL] [Abstract][Full Text] [Related]
22. Significant relationship of matrix metalloproteinase 9 with nuclear grade and prognostic impact of tissue inhibitor of metalloproteinase 2 for incidental clear cell renal cell carcinoma. Kawata N; Nagane Y; Hirakata H; Ichinose T; Okada Y; Yamaguchi K; Takahashi S Urology; 2007 Jun; 69(6):1049-53. PubMed ID: 17572184 [TBL] [Abstract][Full Text] [Related]
23. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators. Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of p53 and matrix metalloproteinase-9 expression in follicular lymphoma. Pennanen H; Kuittinen O; Soini Y; Turpeenniemi-Hujanen T Eur J Haematol; 2008 Oct; 81(4):289-97. PubMed ID: 18616513 [TBL] [Abstract][Full Text] [Related]
25. [Relationship between expression of matrix metalloproteinase (MMP-9) and tumor angiogenesis, cancer cell proliferation, invasion, and metastasis in invasive carcinoma of cervix]. Jiang ZQ; Zhu FC; Qu JY; Zheng X; You CL Ai Zheng; 2003 Feb; 22(2):178-84. PubMed ID: 12600296 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of apoptosis-related markers in urothelial cancer of the upper urinary tract. Jeong IG; Kim SH; Jeon HG; Kim BH; Moon KC; Lee SE; Lee E Hum Pathol; 2009 May; 40(5):668-77. PubMed ID: 19157504 [TBL] [Abstract][Full Text] [Related]
27. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169 [TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma. Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919 [TBL] [Abstract][Full Text] [Related]
29. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Rouprêt M; Fromont G; Azzouzi AR; Catto JW; Vallancien G; Hamdy FC; Cussenot O Urology; 2005 Jun; 65(6):1233-7. PubMed ID: 15922421 [TBL] [Abstract][Full Text] [Related]
30. Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma. Isbarn H; Jeldres C; Shariat SF; Liberman D; Sun M; Lughezzani G; Widmer H; Arjane P; Pharand D; Fisch M; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI J Urol; 2009 Nov; 182(5):2177-81. PubMed ID: 19758662 [TBL] [Abstract][Full Text] [Related]
31. Expression of Ki-67 and COX-2 in patients with upper urinary tract urothelial carcinoma. Jeon HG; Jeong IG; Bae J; Lee JW; Won JK; Paik JH; Kim HH; Lee SE; Lee E Urology; 2010 Aug; 76(2):513.e7-12. PubMed ID: 20573388 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma. Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813 [TBL] [Abstract][Full Text] [Related]
33. Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. Minervini A; Di Cristofano C; Gacci M; Serni S; Menicagli M; Lanciotti M; Salinitri G; Rocca CD; Lapini A; Nesi G; Bevilacqua G; Minervini R; Carini M J Urol; 2008 Oct; 180(4):1284-9. PubMed ID: 18707725 [TBL] [Abstract][Full Text] [Related]
34. Transitional cell carcinomas of the renal pelvis and the ureter: comparative demographic characteristics, pathological grade and stage and 5-year survival in a Taiwanese population. Tan LB; Chang LL; Cheng KI; Huang CH; Kwan AL BJU Int; 2009 Feb; 103(3):312-6. PubMed ID: 18782312 [TBL] [Abstract][Full Text] [Related]
35. Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role. Miyata Y; Iwata T; Maruta S; Kanda S; Nishikido M; Koga S; Kanetake H Eur Urol; 2007 Sep; 52(3):791-7. PubMed ID: 17207914 [TBL] [Abstract][Full Text] [Related]
36. Expression of p27 and its ubiquitin ligase subunit Skp2 in upper urinary tract transitional cell carcinoma. Langner C; von Wasielewski R; Ratschek M; Rehak P; Zigeuner R Urology; 2004 Sep; 64(3):611-6. PubMed ID: 15351619 [TBL] [Abstract][Full Text] [Related]
37. E-cadherin immunoreactivity correlates with recurrence and progression of minimally invasive transitional cell carcinomas of the urinary bladder. Mahnken A; Kausch I; Feller AC; Krüger S Oncol Rep; 2005 Oct; 14(4):1065-70. PubMed ID: 16142373 [TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients. Nathan CO; Amirghahri N; Rice C; Abreo FW; Shi R; Stucker FJ Laryngoscope; 2002 Dec; 112(12):2129-40. PubMed ID: 12461330 [TBL] [Abstract][Full Text] [Related]
39. [A clinicopathological study on carcinoma of the renal pelvis and ureter]. Hashimoto H; Saga Y; Tokumitsu M; Yamaguchi S; Morikawa M; Yachiku S Hinyokika Kiyo; 1997 Oct; 43(10):707-12. PubMed ID: 9395905 [TBL] [Abstract][Full Text] [Related]
40. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract. Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]